GONUTS has been updated to MW1.31 Most things seem to be working but be sure to report problems.
HUMAN:D103A
Contents
Species (Taxon ID) | Homo sapiens (Human). (9606) | |
Gene Name(s) | DEFB103B (synonyms: BD3, DEFB103, DEFB3) | |
Protein Name(s) | Beta-defensin 103
Beta-defensin 3 BD-3 DEFB-3 HBD3 hBD-3 Defensin, beta 103 Defensin-like protein | |
External Links | ||
UniProt | P81534 | |
EMBL | AJ237673 AF295370 AF217245 AB037972 AF301470 AF516673 | |
CCDS | CCDS34810.1 CCDS43701.1 | |
RefSeq | NP_001075020.1 NP_061131.1 XP_016885681.1 | |
UniGene | Hs.283082 Hs.637221 | |
PDB | 1KJ6 | |
PDBsum | 1KJ6 | |
ProteinModelPortal | P81534 | |
SMR | P81534 | |
BioGrid | 120984 | |
IntAct | P81534 | |
STRING | 9606.ENSP00000324633 | |
TCDB | 1.C.85.1.3 | |
BioMuta | DEFB103A | |
DMDM | 17372441 | |
PaxDb | P81534 | |
PRIDE | P81534 | |
DNASU | 414325 55894 | |
Ensembl | ENST00000314357 ENST00000318124 ENST00000613448 | |
GeneID | 414325 55894 | |
KEGG | hsa:414325 hsa:55894 | |
UCSC | uc003wrf.4 | |
CTD | 414325 55894 | |
DisGeNET | 414325 55894 | |
GeneCards | DEFB103A DEFB103B | |
HGNC | HGNC:15967 HGNC:31702 | |
MIM | 606611 | |
neXtProt | NX_P81534 | |
OpenTargets | ENSG00000176797 | |
PharmGKB | PA134933952 | |
eggNOG | ENOG410JFYR ENOG411134U | |
GeneTree | ENSGT00530000064280 | |
HOGENOM | HOG000015465 | |
HOVERGEN | HBG004834 | |
InParanoid | P81534 | |
OMA | IRGGRCA | |
OrthoDB | EOG093719AW | |
PhylomeDB | P81534 | |
Reactome | [www.reactome.org/content/detail/R-HSA-1461957 R-HSA-1461957] [www.reactome.org/content/detail/R-HSA-1461973 R-HSA-1461973] | |
EvolutionaryTrace | P81534 | |
GeneWiki | DEFB103A | |
PRO | PR:P81534 | |
Proteomes | UP000005640 | |
Bgee | ENSG00000176797 | |
CleanEx | HS_DEFB103A HS_DEFB103B | |
Genevisible | P81534 | |
GO | GO:0005576 GO:0005615 GO:0005796 GO:0019730 GO:0042742 GO:0006965 | |
InterPro | IPR001855 | |
Pfam | PF00711 |
Annotations
Qualifier | GO ID | GO term name | Reference | ECO ID | ECO term name | with/from | Aspect | Extension | Notes | Status |
---|---|---|---|---|---|---|---|---|---|---|
GO:0042742 |
defense response to bacterium |
ECO:0000314 |
P |
The bactericidal activity of hBD-3, an abbreviation of human beta-defensin 3 which is an alternative name for human beta-defensin 103, against various clinical isolates was evaluated by a liquid microdilution assay as shown in Figure 1. The results showed that hBD-3 used at a concentration of 4 μg/ml was bactericidal against A. baumannii (strain 3) after 3 min of incubation. hBD-3 used at a concentration of 8 μg/ml caused a bactericidal effect within 20 min of incubation against S. aureus (strain 3), E. faecium (strain 3), and P. aeruginosa (strain 3) and within 1 min against S. maltophilia (strain 4) and A. baumannii. At a concentration of 16 μg/ml, the peptide produced a bactericidal effect against S. aureus, E. faecium, P. aeruginosa, and S. maltophilia within 10, 20, 5, and 1 min, respectively. |
complete | |||||
GO:0051873 |
killing by host of symbiont cells |
ECO:0000314 |
P |
Human Beta-defensin 103, also known as human beta-defensin 3 (hBD-3), has the ability to kill cells of other organisms. The bactericidal activity of hBD-3 against various clinical isolates was evaluated by a liquid microdilution assay as shown in Figure 1. The results of that assay showed that hBD-3 used at a concentration of 4 μg/ml was bactericidal against A. baumannii (strain 3) after 3 min of incubation. hBD-3 used at a concentration of 8 μg/ml caused a bactericidal effect within 20 min of incubation against S. aureus (strain 3), E. faecium (strain 3), and P. aeruginosa (strain 3) and within 1 min against S. maltophilia (strain 4) and A. baumannii. At a concentration of 16 μg/ml, the peptide produced a bactericidal effect against S. aureus, E. faecium, P. aeruginosa, and S. maltophilia within 10, 20, 5, and 1 min, respectively. |
complete | |||||
GO:0002376 |
immune system process |
ECO:0000314 |
P |
Human Beta-defensin 103, also known as human beta-defensin 3 (hBD-3), plays a role in immune system processes. The bactericidal immune activity of hBD-3 against various clinical isolates was evaluated by a liquid microdilution assay as shown in Figure 1. The results of that assay showed that hBD-3 used at a concentration of 4 μg/ml was bactericidal against A. baumannii (strain 3) after 3 min of incubation. hBD-3 used at a concentration of 8 μg/ml caused a bactericidal effect within 20 min of incubation against S. aureus (strain 3), E. faecium (strain 3), and P. aeruginosa (strain 3) and within 1 min against S. maltophilia (strain 4) and A. baumannii. At a concentration of 16 μg/ml, the peptide produced a bactericidal effect against S. aureus, E. faecium, P. aeruginosa, and S. maltophilia within 10, 20, 5, and 1 min, respectively. |
complete | |||||
GO:0016045 |
detection of bacterium |
ECO:0000314 |
P |
Human Beta-defensin 103, also known as human beta-defensin 3 (hBD-3), has the ability to detect bacterial cells and express bactericidal activity against them. The bactericidal activity of hBD-3 against various clinical isolates was evaluated by a liquid microdilution assay as shown in Figure 1. The results of that assay showed that hBD-3 used at a concentration of 4 μg/ml was bactericidal against A. baumannii (strain 3) after 3 min of incubation. hBD-3 used at a concentration of 8 μg/ml caused a bactericidal effect within 20 min of incubation against S. aureus (strain 3), E. faecium (strain 3), and P. aeruginosa (strain 3) and within 1 min against S. maltophilia (strain 4) and A. baumannii. At a concentration of 16 μg/ml, the peptide produced a bactericidal effect against S. aureus, E. faecium, P. aeruginosa, and S. maltophilia within 10, 20, 5, and 1 min, respectively. |
complete | |||||
involved_in |
GO:0050830 |
defense response to Gram-positive bacterium |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
involved_in |
GO:0050829 |
defense response to Gram-negative bacterium |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
involved_in |
GO:0031640 |
killing of cells of other organism |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
involved_in |
GO:0031640 |
killing of cells of other organism |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
involved_in |
GO:0031640 |
killing of cells of other organism |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
involved_in |
GO:0031640 |
killing of cells of other organism |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
involved_in |
GO:0031640 |
killing of cells of other organism |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
involved_in |
GO:0060326 |
cell chemotaxis |
ECO:0000318 |
biological aspect of ancestor evidence used in manual assertion |
MGI:MGI:2675345 |
P |
Seeded From UniProt |
complete | ||
involved_in |
GO:0042742 |
defense response to bacterium |
ECO:0000318 |
biological aspect of ancestor evidence used in manual assertion |
MGI:MGI:1351612 |
P |
Seeded From UniProt |
complete | ||
enables |
GO:0042056 |
chemoattractant activity |
ECO:0000318 |
biological aspect of ancestor evidence used in manual assertion |
MGI:MGI:2675345 |
F |
Seeded From UniProt |
complete | ||
enables |
GO:0031731 |
CCR6 chemokine receptor binding |
ECO:0000318 |
biological aspect of ancestor evidence used in manual assertion |
MGI:MGI:1927667 |
F |
Seeded From UniProt |
complete | ||
involved_in |
GO:0006935 |
chemotaxis |
ECO:0000318 |
biological aspect of ancestor evidence used in manual assertion |
MGI:MGI:1927667 |
P |
Seeded From UniProt |
complete | ||
part_of |
GO:0005615 |
extracellular space |
ECO:0000318 |
biological aspect of ancestor evidence used in manual assertion |
PANTHER:PTN000464032 |
C |
Seeded From UniProt |
complete | ||
involved_in |
GO:0042742 |
defense response to bacterium |
ECO:0000315 |
mutant phenotype evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
part_of |
GO:0005615 |
extracellular space |
ECO:0000314 |
direct assay evidence used in manual assertion |
C |
Seeded From UniProt |
complete | |||
involved_in |
GO:0050918 |
positive chemotaxis |
ECO:0000364 |
evidence based on logical inference from manual annotation used in automatic assertion |
GO:0042056 |
P |
Seeded From UniProt |
complete | ||
part_of |
GO:0005576 |
extracellular region |
ECO:0000256 |
match to sequence model evidence used in automatic assertion |
C |
Seeded From UniProt |
complete | |||
involved_in |
GO:0006952 |
defense response |
ECO:0000256 |
match to sequence model evidence used in automatic assertion |
P |
Seeded From UniProt |
complete | |||
involved_in |
GO:0050830 |
defense response to Gram-positive bacterium |
ECO:0000270 |
expression pattern evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
involved_in |
GO:0050829 |
defense response to Gram-negative bacterium |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
involved_in |
GO:0061844 |
antimicrobial humoral immune response mediated by antimicrobial peptide |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
involved_in |
GO:0031640 |
killing of cells of other organism |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
involved_in |
GO:0031640 |
killing of cells of other organism |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
involved_in |
GO:0031640 |
killing of cells of other organism |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
involved_in |
GO:0031640 |
killing of cells of other organism |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
involved_in |
GO:0031640 |
killing of cells of other organism |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
involved_in |
GO:0031640 |
killing of cells of other organism |
ECO:0000314 |
direct assay evidence used in manual assertion |
P |
Seeded From UniProt |
complete | |||
involved_in |
GO:0019730 |
antimicrobial humoral response |
Reactome:R-HSA-6803157 |
ECO:0000304 |
author statement supported by traceable reference used in manual assertion |
P |
Seeded From UniProt |
complete | ||
part_of |
GO:0005796 |
Golgi lumen |
Reactome:R-HSA-1471322 |
ECO:0000304 |
author statement supported by traceable reference used in manual assertion |
|
C |
Seeded From UniProt |
complete | |
part_of |
GO:0005576 |
extracellular region |
Reactome:R-HSA-1974676 |
ECO:0000304 |
author statement supported by traceable reference used in manual assertion |
|
C |
Seeded From UniProt |
complete | |
involved_in |
GO:0042742 |
defense response to bacterium |
ECO:0000322 |
imported manually asserted information used in automatic assertion |
P |
Seeded From UniProt |
complete | |||
part_of |
GO:0005576 |
extracellular region |
ECO:0000322 |
imported manually asserted information used in automatic assertion |
C |
Seeded From UniProt |
complete | |||
involved_in |
GO:0006952 |
defense response |
ECO:0000322 |
imported manually asserted information used in automatic assertion |
P |
Seeded From UniProt |
complete | |||
Notes
References
See Help:References for how to manage references in GONUTS.
- ↑ 1.0 1.1 1.2 1.3 Maisetta, G et al. (2006) In vitro bactericidal activity of human beta-defensin 3 against multidrug-resistant nosocomial strains. Antimicrob. Agents Chemother. 50 806-9 PubMed GONUTS page
- ↑ 2.0 2.1 2.2 2.3 2.4 2.5 2.6 Schulz, A et al. (2005) Engineering disulfide bonds of the novel human beta-defensins hBD-27 and hBD-28: differences in disulfide formation and biological activity among human beta-defensins. Biopolymers 80 34-49 PubMed GONUTS page
- ↑ 3.0 3.1 3.2 3.3 3.4 3.5 Gaudet, P et al. (2011) Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium. Brief. Bioinformatics 12 449-62 PubMed GONUTS page
- ↑ 4.0 4.1 Augustin, DK et al. (2011) Role of defensins in corneal epithelial barrier function against Pseudomonas aeruginosa traversal. Infect. Immun. 79 595-605 PubMed GONUTS page
- ↑ 5.0 5.1 5.2 5.3 5.4 5.5 5.6 5.7 5.8 Harder, J et al. (2001) Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic. J. Biol. Chem. 276 5707-13 PubMed GONUTS page
a
c
d
e